Immune Checkpoint Inhibitor-Related Alopecia: Insight into the Pathophysiology Using Non-Invasive Diagnostic Techniques
January 2019
in “
Journal of dermatology
”
TLDR Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.
The letter to the editor discussed the pathophysiology of immune checkpoint inhibitor-related alopecia using non-invasive diagnostic techniques. The authors, Misaki Kinoshita-Ise and colleagues, provided insights into how these treatments, which are used in cancer therapy, can lead to hair loss. They emphasized the importance of understanding the underlying mechanisms to better manage and potentially mitigate this side effect. The study highlighted the use of advanced diagnostic tools to observe changes in hair follicles and scalp conditions without the need for invasive procedures.